Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$22.1B
sum of reported positions
Reported positions
660
Changes vs prior quarter
624
41 new · 54 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 354 measured positions in 8 quarters, the typical new or larger position finished +0.0 pts against the S&P 500 and 50% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $19.2B | $22.1B |
| Positions | 673 | 660 |
| Biggest line | — | NVIDIA 6% |
| 2.62M |
| $936M |
| 4.2% |
| 1.69M | $639M | 2.9% |
| 2.6M | $618M | 2.8% |
| 423K | $488M | 2.2% |
| 402K | $482M | 2.2% |
| 658K | $382M | 1.7% |
| 963K | $328M | 1.5% |
| 713K | $309M | 1.4% |
| 843K | $297M | 1.3% |
| 1.16M | $293M | 1.3% |
| 606K | $289M | 1.3% |
| 761K | $229M | 1.0% |
| 644K | $221M | 1.0% |
| 379K | $194M | 0.9% |
| 1.42M | $182M | 0.8% |
| 1.35M | $179M | 0.8% |
| 544K | $178M | 0.8% |
| 2.01M | $176M | 0.8% |
| 347K | $174M | 0.8% |
| 429K | $171M | 0.8% |
| 210K | $159M | 0.7% |
| 271K | $152M | 0.7% |
Danaher Corporation (DHR)
276K → 181K shares (−35%)
Trimble Inc. (TRMB)
707K → 669K shares (−5%)
Zoetis (ZTS)
459K → 475K shares (+4%)
United Rentals (URI)
11K → 30K shares (+173%)
Oruka Therapeutics (ORKA)
411K → 353K shares (−14%)
CVS Health (CVS)
386K → 324K shares (−16%)
Ultragenyx Pharmaceutical (RARE)
1.1M → 1M shares (−9%)
Cg Oncology (CGON)
542K → 469K shares (−13%)
Truist Financial (TFC)
136K → 665K shares (+390%)
Canadian Imperial Bank of Commerce (CM)
298K → 286K shares (−4%)
American Water Works (AWK)
386K → 245K shares (−36%)
eBay Inc. (EBAY)
80K → 283K shares (+251%)
Viridian Therapeutics, Inc. (VRDN)
712K → 1.71M shares (+140%)
CRINETICS PHARMACEUTICALS IN
831K → 819K shares (−1%)
Denali Therapeutics (DNLI)
1.1M → 1.19M shares (+8%)
Adobe (ADBE)
122K → 148K shares (+22%)
Cummins (CMI)
14K → 42K shares (+203%)
Fortinet (FTNT)
329K → 192K shares (−42%)
United Therapeutics (UTHR)
63K → 54K shares (−15%)
Definium Therapeutics (DFTX)
1.29M → 614K shares (−53%)
Mettler Toledo (MTD)
21K → 22K shares (+3%)
RenaissanceRe (RNR)
21K → 89K shares (+325%)
Xenon Pharmaceuticals (XENE)
476K → 463K shares (−3%)
PTC Inc. (PTC)
235K → 244K shares (+4%)
Tapestry, Inc. (TPR)
173K → 185K shares (+7%)
